Dimerix (ASX:DXB) FFO


ASX:DXB Dimerix Ltd ASX:DXB
32 GF Score
Price A$0.20
! 3 Warning Signs
View Full Analysis

What is Dimerix FFO?

FFO (Funds from operations) only applies to REITs.

ASX:DXB
32GF Score
Dimerix Ltd ASX:DXB
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dimerix Business Description

Address 425 Smith Street, Fitzroy, VIC, AUS, 3065
Dimerix Ltd is a biopharmaceutical company developing new therapies in areas with unmet medical needs. The company is developing four product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for COPD, as well as the proprietary ReceptorHIT assay technology. It pursues new product concepts and applies deep scientific knowledge to the discovery of products from early-stage development through to commercialisation. Dimerix products will target multiple territories. The Group has only operated in one Segment, being investment in research and development of biopharmaceutical drugs.
32GF Score

Get the complete analysis for ASX:DXB

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.20
Price